The first monoclonal antibody for cancer
The FDA just approved the first monoclonal antibody for cancer...Rituxan (rituximab) from Genentech.
It's for certain cases of non-Hodgkin's lymphoma
Rituxan binds to an antigen on mature B-cells...allowing the immune system to recognize and eliminate them.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote